Reports for TEVA-MOMETASONE
Brand name
TEVA-MOMETASONE
Company Name
TEVA CANADA LIMITED
|
Drug Identification Number
02248130 |
Ingredients
MOMETASONE FUROATE |
Ingredient Strength
0.1 % |
ATC Code
D07AC |
ATC Descriptor
CORTICOSTEROIDS, PLAIN |
Status
MARKETED
|
Shortage reports
Brand name | Packaging Size | Status | Date Created | Date Updated | Reports |
---|---|---|---|---|---|
TEVA-MOMETASONE | 50G | Resolved | 2017-11-16 | 2018-01-04 | 29441 |
TEVA-MOMETASONE | 50g | Resolved | 2021-02-05 | 2021-02-25 | 133476 |
TEVA-MOMETASONE | 15g | Resolved | 2021-02-25 | 2021-07-15 | 134746 |
TEVA-MOMETASONE | `50g | Resolved | 2021-06-03 | 2021-07-15 | 140387 |
TEVA-MOMETASONE | 50g | Resolved | 2021-07-29 | 2021-09-09 | 143250 |
TEVA-MOMETASONE | 15g | Resolved | 2021-09-23 | 2021-10-28 | 146095 |
TEVA-MOMETASONE | 50 | Resolved | 2022-01-27 | 2022-03-18 | 153730 |
TEVA-MOMETASONE | 15 | Resolved | 2022-02-17 | 2022-04-21 | 155149 |
TEVA-MOMETASONE | 15G | Resolved | 2023-06-19 | 2023-07-05 | 195472 |
TEVA-MOMETASONE | 15 | Resolved | 2022-08-18 | 2023-07-21 | 167209 |
Discontinuation reports
Brand name | Packaging Size | Status | Date Created | Date Updated | Reports |
---|
Showing 1 to 0 of 0